Visit https://www.peervoice.com/FTG860 to view the entire programme with slides. After completing “The Holistic Care of Patients with T2DM: Going Beyond HbA1c”, participants will be able to: Discuss emerging clinical evidence for incretin therapies for type 2 diabetes (T2DM) and how these data may impact future management strategies; Describe the function of incretin hormones and their role in the pathogenesis of T2DM; Recognise the benefits of incretin therapies beyond glycaemic control in patients with T2DM; Apply best practices for the holistic management of patients with T2DM.